HA14-1, a small molecule inhibitor of Bcl-2, bypasses chemoresistance in leukaemia cells

Leukemia Research

Volumn 31, Issue 6, 2007, Pages 859-863

  Oliver, Lisa ^a,b   Mahé, Béatrice ^b   Gréé, René ^c   Vallette, François M ^a,d   Juin, Philippe ^a,d  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

^c Chimie et Photonique Moleculaires Rennes   (France)

^d UNIVERSITÉ DE NANTES   (France)

Author keywords

Bcl 2; Leukaemia; Small molecule inhibitors

Indexed keywords

2 AMINO 6 BROMO 4 (1 CYANO 2 ETHOXY 2 OXOETHYL) 4H CHROMENE 3 CARBOXYLIC ACID ETHYL ESTER; CASPASE 3; DOXORUBICIN; PROTEIN BAX; PROTEIN BCL 2;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CELL DEATH; CELL STRAIN HL 60; CELL STRAIN K 562; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; LYMPHOCYTE; MULTIDRUG RESISTANCE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; WESTERN BLOTTING;

BENZOPYRANS; BLAST CRISIS; CASPASES; CELL DEATH; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LYMPHOCYTES; NITRILES; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 34249825191     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.11.010     Document Type: Article

References (13)

1. Petros A.M., Olejniczak E.T., and Fesik S.W. Structural biology of the Bcl-2 family of proteins. Biochim Biophys Acta 1644 (2004) 83-94
2. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435 (2005) 677-681
3. Real P.J., Cao Y., Wang R., Nikolovska-Coleska Z., Sanz-Ortiz J., Wang S., et al. Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2. Cancer Res 64 (2004) 7947-7953
4. Wang J.L., Liu D., Zhang Z.J., Shan S., Han X., Srinivasula S.M., et al. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc Natl Acad Sci USA 97 (2000) 7124-7129
5. Manero F., Gautier F., Gallenne T., Cauquil N., Gree D., Cartron P.F., et al. The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death. Cancer Res 66 (2006) 2757-2764
6. Zimmermann A.K., Loucks F.A., Le S.S., Butts B.D., Florez-McClure M.L., Bouchard R.J., et al. Distinct mechanisms of neuronal apoptosis are triggered by antagonism of Bcl-2/Bcl-x(L) versus induction of the BH3-only protein Bim. J Neurochem 94 (2005) 22-36
7. Chen J., Freeman A., Liu J., Dai Q., and Lee R.M. The apoptotic effect of HA14-1, a Bcl-2-interacting small molecular compound, requires Bax translocation and is enhanced by PK11195. Mol Cancer Ther 1 (2002) 961-967
8. Lickliter J.D., Wood N.J., Johnson L., McHugh G., Tan J., Wood F., et al. HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death. Leukemia 17 (2003) 2074-2080
9. Oliver L., and Vallette F.M. The role of caspases in cell death and differentiation. Drug Resist Update 8 (2005) 163-170
10. Pelletier M., Cartron P.F., Delaval F., Meflah K., Vallette F.M., and Oliver L. Caspase 3 activation is controlled by a sequence located in the N-terminus of its large subunit. Biochem Biophys Res Commun 316 (2004) 93-99
11. Peters R., Leyvraz S., and Perey L. Apoptotic regulation in primitive hematopoietic precursors. Blood 92 (1998) 2041-2052
12. Lowe S.W., Cepero E., and Evan G. Intrinsic tumour suppression. Nature 432 (2004) 307-315
13. Oliver L., Vavasseur F., Mahe B., Perrin P., Harousseau J.L., Meflah K., et al. Assessment of caspase activity as a possible prognostic factor in acute myeloid leukaemia. Br J Haematol 118 (2002) 434-437